Nutra Pharma Corp (NPHC) Net Cash Flow (2010 - 2026)

Nutra Pharma has disclosed Net Cash Flow across 16 years of filings, most recently posting -$21844.0 for Q2 2026.

• In Q2 2026, Net Cash Flow fell 133.49% year-over-year to -$21844.0; the TTM figure through Jun 2026 stood at -$79069.0 (down 200.0% YoY), while the FY2025 annual figure was -$24266.0, down 166.58% from the prior year.
• Net Cash Flow came in at -$21844.0 for Q2 2026 at Nutra Pharma, down from $9663.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $65226.0 in Q2 2025 to a low of -$83971.0 in Q1 2022.
• Average Net Cash Flow over 4 years is -$8173.6, with a median of $1000.0 recorded in 2024.
• Year-over-year, Net Cash Flow slumped 4898.34% in 2022 and surged 6422.6% in 2025.
• Over 4 years, Net Cash Flow stood at -$10448.0 in 2022, then jumped by 448.84% to $36447.0 in 2024, then sank by 76.46% to $8578.0 in 2025, then tumbled by 354.65% to -$21844.0 in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$21844.0 in Q2 2026, $9663.0 in Q1 2026, and $8578.0 in Q4 2025.